The impact of carbon reduction projects The impact of carbon reduction projects Boehringer Ingelheim voluntarily contributes to carbon reduction projects that benefit sustainable development.
1990-2023: Value through Innovation 1990-2023: Value through Innovation The Boehringer Ingelheim history from 1990 to 2023, with milestones
Boehringer Ingelheim good 2021 business performance Boehringer Ingelheim good 2021 business performance 2021 was a good year for patients, for animal owners and for Boehringer Ingelheim.
Boehringer upgrade in Access to Medicine Health Ranking Boehringer upgrade in Access to Medicine Health Ranking Boehringer’s focus on Health Equity drives significant upgrade in Access to Medicine Index Ranking
Cystic Fibrosis Genetherapy Development Option Excercise Cystic Fibrosis Genetherapy Development Option Excercise Boehringer Ingelheim and Partners Accelerate BI 3720931 Gene Therapy as long-lasting therapeutic option for patients with cystic fibrosis